Aspire Biotech, Inc. was founded in 2001 by a group of experienced biomaterial scientists and medical device engineers. We are a biomaterials R & D company focused on improving medical devices through the development of superior biomaterials. Our core competencies surround the development, formulation, testing, and application of specialty biomaterials.
Innovations by the Aspire team have led to the development of several multi-million dollar products in a variety of medical markets. We have made critical contributions to the development of wound closure systems, gastrointestinal testing systems, wound and tissue sealants, skin protectants, and veterinary tissue adhesives.
Aspire conducts business under the FDA; QSR (21 CFR Part 820) and has significant experience working under quality control regulations and standards, as well as supporting submissions to the FDA.
Quality Policy Statement
"Continually striving to provide superior services from R& D through manufacture that meet or exceed client expectations and industry quality standards."